---
title: "Drug Retail Industry: Companies, KPIs"
description: "3 SEC filers are classified under the Standard Industrial Classification code that describes the drug retail industry."
canonical: https://www.getswoopr.com/stocks/industries/consumer-staples/drug-retail/
source: "Swoopr Investment: https://www.getswoopr.com"
---

# Drug Retail Industry

## Direct Answer

3 SEC filers are classified under the Standard Industrial Classification code that describes the drug retail industry, and their latest annual reports show $403.7 billion of combined revenue and a median operating margin of 1.2%. Investors should still evaluate its revenue model, industry-specific KPIs, valuation framework and the risks that can change the group's economics.

## Industry Overview

Drug retail chains operate pharmacies and front-store merchandise that serve prescription and everyday needs. Margins are squeezed by reimbursement rates and competition, and chains are shrinking store counts. The first numbers to compare across companies here are pharmacy and front-store same-store sales, prescription volume and gross margin and reimbursement.

## Key Industry Metrics

- **Pharmacy and front-store same-store sales**: Sales change at stores open a year or more, shown for prescriptions and for general merchandise. Pharmacy usually grows more but at lower margin, so the split matters.
- **Prescription volume**: The number of prescriptions filled. Rising counts bring in customers who may buy other items, but each script earns little after payer reimbursement.
- **Gross margin and reimbursement**: Profit left after drug costs, driven by the rates paid by insurers and benefit managers. Falling reimbursement can erode margin even as prescription counts grow.
- **Store count**: The number of pharmacies open. Falling counts reflect closures of weak sites and can lift per-store results, but also shrink total reach and sales.
- **Operating margin**: Profit after store, labor and overhead costs as a share of sales. It is thin and sensitive to reimbursement and wage costs, so small shifts matter.

## Primary Macro Drivers

- **Prescription reimbursement rates**: Payers and benefit managers set what pharmacies are paid per prescription, so lower rates cut pharmacy gross margin directly.
- **Drug mix and generics**: Generics carry lower sales but often higher percentage margins than brands, so changes in mix move pharmacy margin and revenue.
- **Front-store traffic**: Shoppers visiting for prescriptions also buy products at higher margins, so traffic and basket size lift front-store sales.
- **Healthcare services expansion**: Clinics, vaccines and testing add revenue beyond dispensing, shown in front-store and pharmacy same-store sales and margin.

## Major Risks

- **Reimbursement pressure from payers**: Falling per-prescription payments can outpace volume gains, so watch pharmacy gross margin against prescription count.
- **Competition from online and mass retailers**: Mail order and discount stores take prescriptions and shoppers, so look at prescription volume and front-store sales for share loss.
- **Store closures**: Closing weak sites cuts sales and triggers lease and restructuring costs, visible in store counts and charges in filings.
- **Litigation such as opioid settlements**: Large legal claims create accruals and cash payments over years, so read the legal contingency notes for the exposure.

## Industry Characteristics

| Characteristic | Profile |
| --- | --- |
| Cyclicality | Defensive |
| Capital Intensity | Medium |
| Regulatory Intensity | High |
| Industry Maturity | Mature |
| Geographic Importance | U.S. |

## Drug Retail Filers in the SEC Record

3 companies with annual reports in the dataset are classified by the SEC in the Standard Industrial Classification code 5912. Their latest fiscal years end between 2025 and 2026, and together they reported $403.7 billion of revenue. Median revenue growth over the prior year was 7.8%. Median operating margin was 1.2% and median net margin 0.4%. Median total liabilities were 64% of total assets, and 2 of 3 reported a profit in their latest year.

| Company | Revenue | Growth | Operating margin | Net margin | Year |
| --- | --- | --- | --- | --- | --- |
| [Cvs Health Corp](https://www.getswoopr.com/stocks/companies/cvs-health/) | $402.1 billion | 7.8% | 1.2% | 0.4% | FY 2025 |
| [Guardian Pharmacy Services, Inc.](https://www.getswoopr.com/stocks/companies/guardian-pharmacy-services-inc/) | $1.4 billion | 17.9% | 5.0% | 3.4% | FY 2025 |
| [Petmed Express Inc](https://www.getswoopr.com/stocks/companies/petmed-express-inc/) | $179 million | -21.1% | -32.8% | -32.0% | FY 2026 |

Source: each company's own annual report as filed with the SEC (XBRL data), figures in U.S. dollars. A company's SIC code reflects its main business as the SEC records it, so it can differ from how an index provider or analyst classifies the company, and a diversified group appears under only one code.

## Where to Go Next

The Drug Retail guide describes how the industry earns money, what to measure and what can go wrong. To see how it compares, read the neighbouring industries in the same sector, then apply the same checks to a specific company.

### More in Consumer Staples

- [Consumer Staples sector overview](https://www.getswoopr.com/stocks/industries/consumer-staples/)
- [Edible Oils](https://www.getswoopr.com/stocks/industries/consumer-staples/edible-oils/)
- [Distillers & Spirits](https://www.getswoopr.com/stocks/industries/consumer-staples/distillers-and-spirits/)
- [Energy Drinks](https://www.getswoopr.com/stocks/industries/consumer-staples/energy-drinks/)
- [Discount Grocery](https://www.getswoopr.com/stocks/industries/consumer-staples/discount-grocery/)
- [Food, Beverage & Tobacco](https://www.getswoopr.com/stocks/industries/consumer-staples/food-beverage-and-tobacco/)
- [Dairy Products](https://www.getswoopr.com/stocks/industries/consumer-staples/dairy-products/)
- [Food Ingredients & Flavors](https://www.getswoopr.com/stocks/industries/consumer-staples/food-ingredients-and-flavors/)
- [Convenience Stores](https://www.getswoopr.com/stocks/industries/consumer-staples/convenience-stores/)

### Put it to work

- [How to analyze a stock](https://www.getswoopr.com/stocks/how-to-analyze-a-stock/)
- [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/)
- [Company research](https://www.getswoopr.com/stocks/companies/)
- [All industries](https://www.getswoopr.com/stocks/industries/)

## Frequently Asked Questions

What are the main KPIs for the Drug Retail industry?

Key performance indicators for the Drug Retail industry include: Pharmacy and front-store same-store sales, Prescription volume, Gross margin and reimbursement, Store count, Operating margin. Which matter most depends on the company's model, so compare them across several companies rather than relying on one.

How cyclical is the Drug Retail industry?

The Drug Retail industry is generally defensive, meaning demand tends to remain relatively stable regardless of the economic cycle. Companies in this space can provide portfolio stability during recessions, though growth may lag in strong expansions.

What are the biggest risks in the Drug Retail industry?

The primary risks for Drug Retail companies include: Reimbursement pressure from payers, Competition from online and mass retailers, Store closures, Litigation such as opioid settlements. Investors should assess each company's exposure to these factors and its track record of navigating them.

**[Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/)**

Swoopr's editorial team produces independent investment education content reviewed for accuracy and clarity. We do not provide personalized financial advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).
